SCPH — Scpharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $208.53m
- $202.03m
- $36.33m
Annual cashflow statement for Scpharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.2 | -28 | -36.8 | -54.8 | -85.1 |
| Depreciation | |||||
| Non-Cash Items | 2.67 | 3.04 | 2.14 | 1.26 | 27.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.45 | -2.6 | -0.35 | -6.32 | -13.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -27.7 | -27.2 | -34.6 | -59.2 | -70.5 |
| Capital Expenditures | — | -0.009 | -0.021 | -0.04 | -0.021 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -33.5 | 32.1 | -45.8 | 20 | 29.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -33.5 | 32.1 | -45.9 | 20 | 29.3 |
| Financing Cash Flow Items | -0.164 | -0.081 | -0.054 | 0 | 20.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 60.3 | -2.53 | 77.2 | 14.8 | 70.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.805 | 2.45 | -3.21 | -24.4 | 28.8 |